-
1Academic Journal
المؤلفون: K. Yu. Morkhov, Yu. M. Kreinina, I. A. Pokataev, V. M. Nechushkina
المصدر: Опухоли женской репродуктивной системы, Vol 18, Iss 1, Pp 87-96 (2022)
مصطلحات موضوعية: endometrial cancer, multidisciplinary approach, immunotherapy, immune checkpoint inhibitors, tyrosine kinase inhibitors, Gynecology and obstetrics, RG1-991
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: D. L. Ovodenko, G. N. Khabas, Yu. M. Kreinina, A. A. Seregin, O. I. Aleshikova, L. A. Ashrafyan
المصدر: Сибирский онкологический журнал, Vol 20, Iss 3, Pp 82-89 (2021)
مصطلحات موضوعية: cervical cancer, neoadjuvant chemotherapy, radical hysterectomy, disease-free survival, chemoembolization, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: M. V. Pavlov, P. I. Rykhtik, O. E. Ilyinskaya, P. V. Subochev, Yu. M. Kreinina, A. V. Maslennikova
المصدر: Сибирский онкологический журнал, Vol 19, Iss 6, Pp 46-56 (2020)
مصطلحات موضوعية: breast cancer, ultrasound diagnostics, energy doppler, neoadjuvant chemotherapy, early tumor response to treatment, tumor blood supply, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: N. V. Dengina, T. Mitin, S. V. Gamayunov, S. Safina, Yu. M. Kreinina, I. V. Tsimafeyeu, Н. В. Деньгина, Т. В. Митин, С. В. Гамаюнов, С. З. Сафина, Ю. М. Крейнина, И. В. Тимофеев
المصدر: Malignant tumours; Том 9, № 3 (2019); 57-64 ; Злокачественные опухоли; Том 9, № 3 (2019); 57-64 ; 2587-6813 ; 2224-5057
مصطلحات موضوعية: иммунотерапия, stereotactic body radiotherapy, targeted therapy, immunotherapy, стереотаксическая лучевая терапия, таргетная терапия
وصف الملف: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/674/464; Tsimafeyeu I, Zolotareva T, Varlamov S, et al. Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry. ClinGenitourin Cancer. 2017 Dec;15 (6):e1069-e1072.; Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J ClinOncol 2006;24:3101-3106.; Alongi F, Arcangeli S, Triggiani L, Mazzolaa R, Buglione di Monale e Bastiac M, Fersinoa S, Baiguini A, Jereczek-Fossa BA, Magrini SM. Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. Critical Reviews in Oncology/Hematology 2017;117:48-56; Dengina N, Tsimafeyeu I, Mitin T. Current role of radiotherapy for renal-cell carcinoma: review. Clinical Genitourinary Cancer 2017;15 (2):183 -187.; Cancer Genome Atlas Research Network, 2013. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-49.; Kim WH, Kim DG, Han JH, Paek SH, Chung HT, Park CK., et al. Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival. Int J RadiatOncolBiolPhys. 2012;82 (5):1749 - 55.; Amini, A., Altoos, B., Bourlon, M. T., Bedrick, E., Bhatia, S., Kessler, E. R., et al. Local control rates of metastatic renal cell carcinoma (RCC) to the bone usingstereotactic body radiation therapy: is RCC truly radioresistant? Pract. Radiat. Oncol. 2015;5 (6):e589 — e596.; Ranck, M. C., Golden, D. W., Corbin, K. S., Hasselle, M. D., Liauw, S. L., Stadler, W. M., et al. Stereotactic body radiotherapy for the treatment ofoligometastatic renal cell carcinoma. Am.J. Clin. Oncol. 2013;36 (6):589-595.; De Wolf K, Vermaelen K, De Meerleer G, Lambrecht BN, Ost P. The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. Oncoimmunology. 2015 May 27;4 (10):e1042198.; Folkert MR, Timmerman RD. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT). Advanced Drug Delivery Reviews 2017;109:3-14.; Motzer RJ, Escudier B, McDermott DF, Geogre S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 2015;373:1803 -1813.; Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. RadiotherOncol 1984;2 (4):317 - 323.; Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer. 1997;80 (12):2519 - 2528.; Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., et al. Tumor response to radiotherapyregulated by endothelial cell apoptosis. Science 2003;300 (5622):1155 -1159.; Qian, C. N., Huang, D., Wondergem, B., Teh, B. T. Complexity of tumorvasculature in clear cell renal cell carcinoma. Cancer 2009;115 (10 Suppl): 2282-2289.; De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P., et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol. 2014 Apr;15 (4):e170-7.; Park S, Kim KH, Rhee WJ, LeeJ, Cho Y, Koom WS. Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma. RadiatOncol J 2016;34 (2):128- 134.; Ishiyama H, Teh BS, Ren H, Chiang S, Tann A, Blanco AI, Paulino AC, Amato R. Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier? ClinGenitourin Cancer 2012; 10 (3):196-8.; Wersall PJ, Blomgren H, Pisa P, Lax I, Kalkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. ActaOncol2006; 45 (4):493-7.; Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S. DNA exonuclease Trex1 regulates radiotherapy-induced tumor immunogenicity. Nat Commun 2017;8:15618 DOI:10.1038; https://www.malignanttumors.org/jour/article/view/674
-
5
المؤلفون: N. A. Khoronenko, A.Yu. Pavlov, V.A. Solodky, K. R. Shakhbazyan, Z. G. Tsallagova, Yu. M. Kreinina
المصدر: Onkologiya. Zhurnal imeni P.A.Gertsena. 8:263
مصطلحات موضوعية: medicine.medical_specialty, Combined treatment, business.industry, Endovascular surgery, Medicine, business, Surgery
-
6
المؤلفون: V A, Titova, L N, Shevchenko, Yu M, Kreinina, V Yu, Petrovsky
المصدر: Voprosy onkologii. 61(4)
مصطلحات موضوعية: Adult, Vaginal Neoplasms, Vulvar Neoplasms, Genital Neoplasms, Female, Lasers, Brachytherapy, Uterine Cervical Neoplasms, Antineoplastic Agents, Chemoradiotherapy, Hyperthermia, Induced, Middle Aged, Combined Modality Therapy, Endometrial Neoplasms, Treatment Outcome, Drug Resistance, Neoplasm, Humans, Female, Aged
-
7
المؤلفون: Yu M, Kreinina, L N, Shevchenko, V A, Titova, A F, Teliyants
المصدر: Voprosy onkologii. 61(4)
مصطلحات موضوعية: Adult, Urologic Diseases, Genital Neoplasms, Female, Radiotherapy Planning, Computer-Assisted, Brachytherapy, Radiotherapy Dosage, Constriction, Pathologic, Middle Aged, Treatment Outcome, Humans, Female, Radiotherapy, Conformal, Aged, Retrospective Studies